Executive Director, Asset Strategy Leadership

BioSpace; New York (NY); Hybrid; USD 297,000 - 356,000; Full time

Benefits offered by this job

Annual bonus

Equity compensation

Comprehensive benefits

Job summary

Recursion is seeking an Executive Director, Asset Strategy Leadership, to shape portfolio strategy across oncology and immunology assets. You will translate computational insights into strategic advantages and collaborate with clinical, BD, finance, and platform teams to optimize resource allocation.

The role blends science leadership with business acumen, driving asset differentiation, regulatory alignment, and patient impact at scale.

Qualifications

• PhD in life sciences with drug discovery experience.
• 10+ years biotech/pharma asset leadership with clinical-stage impact.
• Experience leveraging computational data-driven platforms to inform strategy.

Responsibilities

• Define and drive asset strategy for small molecule clinical programs across oncology and immunology/inflammation.
• Translate AI/Computational insights into asset advantages for portfolio advancement.
• Develop and pressure-test the competitive narrative for oncology and I&I assets with supporting evidence.
• Partner with clinical development, BD, finance and platform teams to align resource allocation with strategic conviction.
• Raise the bar on asset differentiation and delivery to patients with unmet needs.

Skills

Executive leadership

Strategic thinking

Data-driven decisions

Cross-functional collaboration

Regulatory & market awareness

Education

PhD in life sciences

Tools

Data analysis tools

AI platforms

Job description

Your work will change lives. Including your own.

The Impact You’ll Make

As the Recursion clinical asset pipeline continues to mature through key inflection points, the advancing assets require leaders who can translate scientific complexity into strategic clarity. In the role of Executive Director, Asset Strategy Leadership, you will drive the strategic positioning of assets, ensuring that decisioning is grounded in competitive reality, differentiated by Recursion OS insights, and built to move with urgency for patient benefit. You will play a pivotal role ensuring advanced computational approaches and proprietary Recursion OS/ClinTech advantages are leveraged across the portfolio continuum, redefining traditional paradigms of drug development. Working across functional lines, you will partner with preclinical, clinical and platform teams, promoting communication, alignment and optimization of functional processes to ensure delivery of portfolio goals & transformative medicines for patients.

In This Role, You Will

• Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation — integrating competitive positioning, mechanistic differentiation, biomarker strategy, and patient segmentation to sharpen go/no-go and prioritization decisions across the portfolio
• Translate Recursion OS and ClinTech insights into strategic asset advantages, ensuring proprietary data and computational insights are maximally enabling for advancement of the drug discovery and development portfolio
• Develop and pressure-test the competitive narrative for each oncology and I&I portfolio asset, building the evidence base that will inform leadership decisions, partnering discussions and investor communications
• Partner with functional line leaders across clinical development, BD, finance and platform teams to ensure resource allocation reflects strategic conviction and supports the most impactful programs and workstreams
• Propagate the Recursion mindset of radically changing lives by continuously raising the bar on how assets are advanced, differentiated, and delivered to patients with significant unmet need

The Team You’ll Join

As an Executive Director, Asset Strategy Leadership, you will work across the asset portfolio, operating as a senior strategic partner to leaders in Clinical Development, Discovery, ClinTech, Platform and BD. The Portfolio Team is execution-minded and analytically rigorous — fluent in both science and AI — and responsible for industrializing Recursion's innovative science to advance medicines that matter. We break traditional silos, leveraging AI-powered platforms across data analysis, predictive modeling, RWE integration and patient stratification, all with the goal of optimizing asset positioning for the greatest benefit to patients.

The Experience You’ll Need

• A PhD in life sciences or related scientific discipline with deep expertise in drug discovery & development required
• 10+ years of biotech/pharma experience with a proven track record of asset-level strategic leadership, advancing programs through clinical stage-gates with demonstrable impact on portfolio value
• Deep expertise in the development of small molecule therapeutics for oncology and immunology/inflammation required, expertise in rare disease a bonus
• Experience leveraging computational approaches and data-driven platforms to sharpen asset strategy and clinical decision-making
• Proven ability to build and articulate the strategic and competitive case for clinical assets – integrating mechanistic differentiation, competitive dynamics, regulatory and market considerations.
• Strong financial acumen; able to engage credibly on cross-functional resourcing, asset valuation, and portfolio trade-offs
• Exceptional executive presence – able to synthesize complexity into clear, conviction-led recommendations and present with confidence to senior leadership and external partners

Working Location & Compensation:

This is an office-based, hybrid role in our New York City offices. Employees are expected to work in the office at least 50% of the time.

At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is:$297,000–$356,400. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.

The Values We Hope You Share

• We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
• We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
• We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
• We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day.
• We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
• We are One Recursion. True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.

Accommodations are available on request for candidates taking part in all aspects of the selection process.

Recursion leverages AI in our hiring process.

We use Greenhouse's Talent Matching AI technology feature to help review applications against the skills and experience we've identified as important for this role. It analyzes your resume and application responses to assess how closely your qualifications match our criteria - but all decisions are made by our human recruiters and hiring managers, including whether to move to the next phase of review. Talent Matching does not automatically advance or reject any candidate. By submitting your application, you acknowledge that you have been informed about and consent to this use of the Talent Matching tool in our review process. Please refer to our Recursion Privacy Policy athttps://www.recursion.com/privacy-notice/ for more information about our processing of personal data and your rights.

Recruitment & Staffing Agencies:

Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.